Abstract:BACKGROUNDThe main drivers of Glioblastoma (GBM) tumor growth are elevated angiogenesis and heightened characteristics of stemness. These driving factors make GBM an extremely invasive and aggressive tumor. While the GBM tumor microenvironment can be classified into several molecular subtypes, one common characteristic is the atypical induction of various signal transduction pathways including the receptor tyrosine kinases (RTKs), pro-angiogenic, and stem-cell-determining transcription factors, which all play important roles in GBM tumor formation, growth, and progression. OBJECTIVETo investigate the regulations of RTKs, pro-angiogenic, and stem-cell–determining transcription factors in two different tumor environments - monolayer cultures that induce a more differentiated state and neurosphere cultures that select for stem-like cells. METHODSNeurosphere- and monolayer-forming cell samples were cultured from four primary GBM cell lines including HK-336, HK-374, U87, and GS-154. RNA sequencing was performed at the Technology Center for Genomics and Bioinformatics at the University of California, Los Angeles. The transcriptomic data findings were validated by qPCR and western blot assays. RESULTSOur transcriptomic data revealed the significant upregulation of EGFR, PDGFR-α, VEGFA, and SOX2 in the neurosphere-forming HK-336, HK-374, U87, and GS-154 primary GBM cells. Consistent with the transcriptomic data, western blot, and qPCR assays demonstrated significantly higher expressions of these genes in the neurosphere-forming compared to the monolayer-forming GBM cells. Neurosphere-forming GBM cells possess stem-cell-like characteristics with the ability to self-renew and differentiate via the induction of various genes and disease progression pathways. CONCLUSIONSNeurosphere-forming GBM cells demonstrate upregulation of SOX2, EGFR, PDGFR-α, and VEGFA in RNA sequencing, western blot, and qPCR assays. Multipotent drug therapies designed to target multiple gene regulation pathways involving RTKs, pro-angiogenic, and stem-cell-determining transcription factors may be necessary to effectively treat GBM. Understanding the underlying mechanisms driving these aberrant cellular pathways could provide valuable insights for developing targeted therapies against this aggressive brain cancer.

Analysis of Gene Expression Profiles in the Differentiation Process of Glioma Stem Cells to Endothelial Cells

Analysis of gene expression profiles associated with glioma progression.

ENDOTHELIAL CELL TRANSDIFFERENTIATION OF HUMAN GLIOMA STEM/PROGENITOR CELLS IN VITRO

[Preliminary Study on Differentiation-Inducing Associated Genes of Human Brain Glioma Cells in Vitro].

Machine learning-based identification of lower grade glioma stemness subtypes discriminates patient prognosis and drug response

Glioblastoma Stem Cell Differentiation into Endothelial Cells Evidenced Through Live-Cell Imaging.

Tmic-82. Characterization Of Genetic Markers And Biological Processes Underlying The Transition Of Glioblastoma Cells From A Differentiated To A Stem-Cell-Like State

Research on Related Molecules of Differentiation and Malignant Progession of Glioma Cells

Quantitative analysis for the differences in vasculogenic activity and sensitivity to angiogenic stimulants between human glioma cells and normal endothelial cells

Gene Expression Profiling of Glioblastoma to Recognize Potential Biomarker Candidates

From single-cell to spatial transcriptomics: decoding the glioma stem cell niche and its clinical implications

Glioma stem cell signature predicts the prognosis and the response to tumor treating fields treatment

High Expression of VEGF and PI3K in Glioma Stem Cells Provides New Criteria for the Grading of Gliomas.

Expression of Glioma Differentiation-Inducing Associated Genes in Human Glioma Tissues

Molecular Study on Differentiation-Associated Glioma and Di讹renfiafion of Human FetaI NeuraI Stem Cells

Identification and Verification of Candidate Genes Regulating Neural Stem Cells Behavior Under Hypoxia.

Identification of Prognostic Model and Biomarkers for Cancer Stem Cell Characteristics in Glioblastoma by Network Analysis of Multi-Omics Data and Stemness Indices

Molecular Study on Differentiation-Associated Genes Involved in Both Malignant Progression of Glioma and Differentiation of Human Fetal Neural Stem Cells

Experimental Study of Real-Time Monitoring of Glioma Stem Cell Differentiation Process

Exploring potential therapeutic targets for glioma based on non-targeted metabolic analysis

Analysis of Differentially Expressed Genes Based on Microarray Data of Glioma.